Whitepaper

To make good on exciting cell and gene therapy developments, quality control (QC) microbiology labs must evolve to handle more complex processes, unique scale-up needs, reduced “vein-to-vein” timelines, and demanding requirements for lot release. Fortunately, careful planning and advanced technologies can open the door to productive and safe scale-up manufacturing.

This whitepaper identifies key challenges now being successfully resolved via automation, with special emphasis on managing QC for the most complex cell therapies.

VIEW THE WHITEPAPER